Andere Sprachen Acarix AB

Aktien

A2DJR2

SE0009268717

ACARIX

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 17:29:30 24.05.2024			% 5 Tage	% 1. Jan.
0.3195 ^SEK	+2.08%		+1.59%	+68.34%

14.05.	Transcript : Acarix AB, Q1 2024 Earnings Call, May 14, 2024
14.05.	Acarix AB (publ) genehmigt Vorstandswahlen	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Acarix CPT III Code Removed from United Healthcare Medicare Advantage Noncovered List	20.05.
Acarix Q1 2024 - Soft sales but strong outlook	15.05.
Announcement from the annual general meeting in Acarix AB	14.05.
Acarix AB Approves Board Elections	14.05.
Acarix AB (publ) publishes Interim Report, January – March 2024	14.05.
Acarix AB Reports Earnings Results for the First Quarter Ended March 31, 2024	14.05.
Acarix secures a multi-unit order from major cardiology practice with several offices in Florida	13.05.
Invitation to presentation of Acarix´s first quarter report	10.05.
CADScor System is now being utilized by Leading Cardiology Practice in the New York Capital Region	06.05.
Proposal by the nomination committee prior to the 2024 annual general meeting of Acarix AB (publ)	03.05.
Acarix receives order from the first freestanding Emergency Room in the US	29.04.
Acarix Receives Order from the First Freestanding Emergency Room in the Us	29.04.
Acarix AB’s Annual Report 2023	23.04.
NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB	11.04.
Acarix announces the initiation of the first US-based clinical workflow evaluation study	11.04.
Acarix AB Announces Initiation of the First Us-Based Clinical Workflow Evaluation Study	11.04.
Acarix adopts new growth-focused business model and provides outlook update as part of our ongoing strategic review	11.04.
New Health Economic Analysis Presented at ACC Highlights The Acarix CADScor System’s Cost-Effectiveness	08.04.
Acarix Announces the Results from 2024 American College of Cardiology Poster Presentation to Assess the Cost-Utility of the Cadscor System	08.04.
Acarix has submitted application for cross-trading at OTCQB in the US	05.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Acarix AB

Aktien

A2DJR2

SE0009268717

ACARIX

Andere Sprachen

Filter